Sudden cardiac arrest risk assessment: Population science and the individual risk mandate

JAMA Cardiology

Volumn 2, Issue 6, 2017, Pages 689-694

  Myerburg, Robert J ^a,b   Goldberger, Jeffrey J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; FAMILY HISTORY; GENETIC PREDISPOSITION; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SUDDEN CARDIAC DEATH; POPULATION HEALTH; RISK FACTOR;

DEATH, SUDDEN, CARDIAC; HUMANS; POPULATION HEALTH; RISK ASSESSMENT; RISK FACTORS;

EID: 85031704930     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2017.0266     Document Type: Review

References (39)

1. Khoury MJ, Galea S. Will precision medicine improve population health? JAMA. 2016;316(13): 1357-1358.
2. Goldberger JJ, Buxton AE. Personalized medicine vs guideline-based medicine. JAMA. 2013; 309(24):2559-2560.
3. Hunter DJ. Uncertainty in the era of precision medicine. N Engl J Med. 2016;375(8):711-713.
4. Myerburg RJ, Mitrani R, Interian A Jr, Castellanos A. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation. 1998;97(15):1514-1521.
5. Mozaffarian D, Benjamin EJ, Go AS, et al;Writing Group Members; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2016 update: a report from the american heart association. Circulation. 2016;133(4):e38-e360.
6. Merchant RM, Yang L, Becker LB, et al; American Heart Association Get With The Guidelines-Resuscitation Investigators. Incidence of treated cardiac arrest in hospitalized patients in the United States. Crit Care Med. 2011;39(11):2401-2406.
7. Chan PS. Public health burden of in-hospital cardiac arrest. http://www.nationalacademies.org/hmd/~/media/Files/Report%20Files/2015/GWTG.pdf. Published 2015. Accessed April 28, 2016.
8. Daya MR, Schmicker R, May SH, Morrison LJ. Current burden of cardiac arrest in the United States: report from the Resuscitation Outcomes Consortium. http://www.nationalacademies.org/hmd/~/media/Files/Report%20Files/2015/ROC.pdf. Published 2015. Accessed April 28, 2016.
9. Myerburg RJ. Electrocardiographic screening of children and adolescents: the search for hidden risk. Eur Heart J. 2016;37(31):2498-2501.
10. IOM (Institute of Medicine). Committee on the Treatment of Cardiac Arrest: Current Status and Future Directions: Strategies to Improve Cardiac Arrest Survival: A Time to Act. Washington, DC: The National Academies Press; 2015.
11. Goldberger JJ, Buxton AE, Cain M, et al. Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks. Circulation. 2011;123(21): 2423-2430.
12. Fishman GI, Chugh SS, Dimarco JP, et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation. 2010;122(22):2335-2348.
13. Stecker EC, Reinier K, Marijon E, et al. Public health burden of sudden cardiac death in the United States. Circ Arrhythm Electrophysiol. 2014;7 (2):212-217.
14. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125(8):1043-1052.
15. Goldberger JJ, Basu A, Boineau R, et al. Risk stratification for sudden cardiac death: a plan for the future. Circulation. 2014;129(4):516-526.
16. Wellens HJ, Schwartz PJ, Lindemans FW, et al. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J. 2014;35(25):1642-1651.
17. Myerburg RJ. Physiological variations, environmental factors, and genetic modifications in inherited LQT syndromes. J Am Coll Cardiol. 2015; 65(4):375-377.
18. Friedlander Y, Siscovick DS, Weinmann S, et al. Family history as a risk factor for primary cardiac arrest. Circulation. 1998;97(2):155-160.
19. Jouven X, Desnos M, Guerot C, Ducimetière P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation. 1999;99(15): 1978-1983.
20. Dekker LR, Bezzina CR, Henriques JP, et al. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acutemyocardial infarction patients. Circulation. 2006;114(11):1140-1145.
21. Kaikkonen KS, Kortelainen ML, Linna E, Huikuri HV. Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation. 2006;114(14):1462-1467.
22. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Mann DL, Zipes DP, Libby P, Bonow RO, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed. Oxford, England: Elsevier; 2015.
23. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356(23):2388-2398.
24. Myerburg RJ. Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med. 2008;359(21):2245-2253.
25. Myerburg RJ, Reddy V, Castellanos A. Indications for implantable cardioverter-defibrillators based on evidence and judgment. J AmColl Cardiol. 2009;54(9):747-763.
26. Stecker EC, Vickers C, Waltz J, et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J AmColl Cardiol. 2006;47(6):1161-1166.
27. Wong MK, Morrison LJ, Qiu F, et al. Trends in short- and long-term survival among out-of-hospital cardiac arrest patients alive at hospital arrival. Circulation. 2014;130(21):1883-1890.
28. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med. 2006;355(25): 2615-2617.
29. Deo R, Norby FL, Katz R, et al. Development and validation of a sudden cardiac death prediction model for the general population. Circulation. 2016; 134(11):806-816.
30. Puymirat E, Simon T, Steg PG, et al; USIK USIC 2000 Investigators; FAST MI Investigators. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012;308(10):998-1006.
31. Mäkikallio TH, Barthel P, Schneider R, et al. Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy. Am J Cardiol. 2006;97(4):480-484.
32. Køber L, Thune JJ, Nielsen JC, et al; DANISH Investigators. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375(13):1221-1230.
33. Junttila MJ, Barthel P, Myerburg RJ, et al. Sudden cardiac death aftermyocardial infarction in patients with type 2 diabetes. Heart Rhythm. 2010;7(10):1396-1403.
34. Brooks GC, Lee BK, Rao R, et al; PREDICTS Investigators. Predicting persistent left ventricular dysfunction followingmyocardial infarction: the PREDICTS study. J AmColl Cardiol. 2016;67(10): 1186-1196.
35. Bardy GH, Lee KL, Mark DB, et al; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-237.
36. Exner DV, Kavanagh KM, Slawnych MP, et al; REFINE Investigators. Noninvasive risk assessment early after amyocardial infarction the REFINE study. J AmColl Cardiol. 2007;50(24):2275-2284.
37. Exner D. Noninvasive risk stratification after myocardial infarction: rationale, current evidence and the need for definitive trials. Can J Cardiol. 2009;25(suppl A):21A-27A.
38. Myerburg RJ, Ullmann SG. Alternative research funding to improve clinical outcomes: model of prediction and prevention of sudden cardiac death. Circ Arrhythm Electrophysiol. 2015;8(2):492-498.
39. Kida K, Ichinose F. Preventing ischemic brain injury after sudden cardiac arrest using NO inhalation. Crit Care. 2014;18(2):212-217.